Cargando…
2255. The Use of Dalbavancin for Staphylococcus aureus Bacteremia in Persons Who Inject Drugs (PWID)
BACKGROUND: Staphylococcus aureus is a significant cause of bacteremia and is associated with high morbidity and mortality rates. In patients with S. aureus bacteremia, studies have proven that intravenous antibiotics are needed for the entire course of therapy. For some groups of patients, specific...
Autores principales: | Van Hise, Nicholas W, Anderson, Michael, McKinsey, David, McKinsey, Joel, Harting, Brian, Belmares, Jaime, Petrak, Russell M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809537/ http://dx.doi.org/10.1093/ofid/ofz360.1933 |
Ejemplares similares
-
Arcanobacterium Brain Abscesses, Subdural Empyema, and Bacteremia Complicating Epstein-Barr Virus Mononucleosis
por: Poplin, Victoria, et al.
Publicado: (2018) -
225. Dalbavancin Usage in Patients Who Inject Drugs (PWID)
por: Patel, Kaya, et al.
Publicado: (2023) -
Dalbavancin for Staphylococcus aureus Bacteremia: Are We There Yet?
por: Mahatanan, Rattanaporn, et al.
Publicado: (2023) -
Value: The Four Cornerstones of Corporate Finance
por: Company, McKinsey
Publicado: (2010) -
Treatment and Prevention of Histoplasmosis in Adults Living with HIV
por: McKinsey, David S.
Publicado: (2021)